Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Arthur F Ryan. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Arthur F Ryan har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:REGN / Regeneron Pharmaceuticals, Inc. | Director | 17 748 |
US:CFG / Citizens Financial Group, Inc. | Director | 60 994 |
Director | 2 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Arthur F Ryan. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Arthur F Ryan som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 166 | 17 748 | 0,94 | ||||
2024-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 17 582 | −0,01 | 1 059,28 | −2 119 | 18 624 261 |
2024-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 17 584 | −0,01 | 1 057,38 | −2 115 | 18 592 970 |
2024-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 17 586 | −0,02 | 1 056,68 | −3 170 | 18 582 774 |
2024-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 17 589 | −0,02 | 1 054,90 | −3 165 | 18 554 636 |
2024-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 17 592 | −0,02 | 1 053,45 | −4 214 | 18 532 292 |
2024-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 17 596 | −0,02 | 1 052,44 | −4 210 | 18 518 734 |
2024-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 17 600 | −0,05 | 1 051,51 | −9 464 | 18 506 576 |
2024-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 17 609 | −0,03 | 1 050,60 | −6 304 | 18 500 015 |
2024-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 17 615 | −0,05 | 1 049,68 | −9 447 | 18 490 113 |
2024-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 17 624 | −0,07 | 1 048,54 | −12 582 | 18 479 469 |
2024-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 17 636 | −0,07 | 1 047,44 | −12 569 | 18 472 652 |
2024-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 17 648 | −0,05 | 1 046,53 | −9 419 | 18 469 161 |
2024-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 17 657 | −0,04 | 1 045,27 | −7 317 | 18 456 332 |
2024-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 17 664 | −0,05 | 1 044,62 | −9 402 | 18 452 168 |
2024-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 17 673 | −0,03 | 1 043,39 | −5 217 | 18 439 831 |
2024-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 17 678 | −0,01 | 1 042,31 | −1 042 | 18 425 956 |
2024-10-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 17 679 | −0,02 | 1 041,35 | −3 124 | 18 410 027 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 17 682 | −0,02 | 1 191,02 | −4 764 | 21 059 616 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 17 686 | −0,01 | 1 190,00 | −1 190 | 21 046 340 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 17 687 | −0,03 | 1 189,13 | −5 946 | 21 032 142 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 17 692 | −0,02 | 1 188,55 | −4 754 | 21 027 827 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 17 696 | −0,02 | 1 187,95 | −3 564 | 21 021 963 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 17 699 | −0,03 | 1 186,19 | −5 931 | 20 994 377 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 17 704 | −0,02 | 1 185,77 | −4 743 | 20 992 872 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 17 708 | −0,01 | 1 184,26 | −1 184 | 20 970 876 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 | 17 709 | −0,05 | 1 183,47 | −9 468 | 20 958 070 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 | 17 717 | −0,05 | 1 179,62 | −9 437 | 20 899 328 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 17 725 | −0,02 | 1 178,69 | −4 715 | 20 892 280 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 17 729 | −0,02 | 1 177,73 | −4 711 | 20 879 975 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 17 733 | −0,02 | 1 176,82 | −4 707 | 20 868 549 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 | 17 737 | −0,05 | 1 175,66 | −9 405 | 20 852 681 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 | 17 745 | −0,05 | 1 174,32 | −9 395 | 20 838 308 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −16 | 17 753 | −0,09 | 1 172,75 | −18 764 | 20 819 831 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 17 769 | −0,02 | 1 170,40 | −4 682 | 20 796 838 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 17 773 | −0,02 | 1 168,99 | −4 676 | 20 776 459 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 17 777 | −0,01 | 1 167,27 | −1 167 | 20 750 559 |
2024-09-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 17 778 | −0,02 | 1 166,52 | −4 666 | 20 738 393 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 17 782 | −0,01 | 1 100,03 | −1 100 | 19 560 733 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 17 783 | −0,02 | 1 099,65 | −3 299 | 19 555 076 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 17 786 | −0,01 | 1 098,00 | −1 098 | 19 529 028 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 17 787 | −0,02 | 1 097,69 | −3 293 | 19 524 612 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 17 790 | −0,02 | 1 096,19 | −3 289 | 19 501 220 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 17 793 | −0,02 | 1 095,35 | −3 286 | 19 489 563 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 17 796 | −0,01 | 1 094,02 | −1 094 | 19 469 180 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 17 797 | −0,04 | 1 093,39 | −7 654 | 19 459 062 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 17 804 | −0,04 | 1 092,61 | −7 648 | 19 452 828 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −13 | 17 811 | −0,07 | 1 091,47 | −14 189 | 19 440 172 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 | 17 824 | −0,06 | 1 090,30 | −11 993 | 19 433 507 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 17 835 | −0,04 | 1 089,64 | −7 627 | 19 433 729 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 17 842 | −0,02 | 1 088,70 | −3 266 | 19 424 585 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 17 845 | −0,01 | 1 087,54 | −2 175 | 19 407 151 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 17 847 | −0,01 | 1 086,38 | −2 173 | 19 388 624 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 17 849 | −0,02 | 1 085,71 | −3 257 | 19 378 838 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 17 852 | −0,02 | 1 084,71 | −3 254 | 19 364 243 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 17 855 | −0,01 | 1 083,57 | −1 084 | 19 347 142 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 17 856 | −0,01 | 1 082,17 | −1 082 | 19 323 228 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 17 857 | −0,01 | 1 080,06 | −1 080 | 19 286 631 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 17 858 | −0,02 | 1 076,07 | −3 228 | 19 216 458 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 17 861 | −0,01 | 1 074,34 | −1 074 | 19 188 787 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 17 862 | −0,01 | 1 073,03 | −1 073 | 19 166 462 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 17 863 | −0,02 | 1 070,46 | −4 282 | 19 121 627 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 17 867 | −0,01 | 1 068,08 | −1 068 | 19 083 385 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 17 868 | −0,01 | 1 067,53 | −1 068 | 19 074 626 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 17 869 | −0,02 | 1 066,33 | −4 265 | 19 054 251 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 17 873 | −0,03 | 1 065,39 | −6 392 | 19 041 715 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 17 879 | −0,01 | 1 062,71 | −1 063 | 19 000 192 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 17 880 | −0,01 | 1 058,90 | −1 059 | 18 933 132 |
2024-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 17 881 | −0,01 | 1 053,22 | −1 053 | 18 832 627 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 17 882 | −0,01 | 1 068,09 | −2 136 | 19 099 585 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 17 884 | −0,02 | 1 067,51 | −3 203 | 19 091 349 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 17 887 | −0,02 | 1 066,59 | −4 266 | 19 078 095 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 17 891 | −0,02 | 1 065,52 | −3 197 | 19 063 218 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 17 894 | −0,04 | 1 064,55 | −7 452 | 19 049 058 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 17 901 | −0,03 | 1 063,87 | −5 319 | 19 044 337 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −19 | 17 906 | −0,11 | 1 062,31 | −20 184 | 19 021 723 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 17 925 | −0,02 | 1 061,73 | −3 185 | 19 031 510 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 17 928 | −0,02 | 1 060,14 | −3 180 | 19 006 190 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 17 931 | −0,02 | 1 059,36 | −3 178 | 18 995 384 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −17 | 17 934 | −0,09 | 1 058,49 | −17 994 | 18 982 960 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 17 951 | −0,01 | 1 057,64 | −2 115 | 18 985 696 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 17 953 | −0,01 | 1 056,81 | −2 114 | 18 972 910 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 17 955 | −0,01 | 1 054,25 | −1 054 | 18 929 059 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 | 17 956 | −0,04 | 1 053,60 | −8 429 | 18 918 442 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 17 964 | −0,03 | 1 052,19 | −6 313 | 18 901 541 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 17 970 | −0,04 | 1 051,58 | −7 361 | 18 896 893 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 17 977 | −0,01 | 1 050,87 | −2 102 | 18 891 490 |
2024-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 17 979 | −0,02 | 1 047,11 | −3 141 | 18 825 991 |
2024-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 17 982 | −0,03 | 1 000,04 | −5 000 | 17 982 719 |
2024-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 17 987 | −0,04 | 999,43 | −6 996 | 17 976 747 |
2024-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −14 | 17 994 | −0,08 | 998,44 | −13 978 | 17 965 929 |
2024-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −15 | 18 008 | −0,08 | 997,76 | −14 966 | 17 967 662 |
2024-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 18 023 | −0,07 | 996,83 | −11 962 | 17 965 867 |
2024-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 18 035 | −0,03 | 995,76 | −5 975 | 17 958 532 |
2024-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 18 041 | −0,03 | 994,25 | −4 971 | 17 937 264 |
2024-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 18 046 | −0,07 | 993,20 | −11 918 | 17 923 287 |
2024-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 18 058 | −0,04 | 992,19 | −6 945 | 17 916 967 |
2024-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 18 065 | −0,02 | 990,74 | −3 963 | 17 897 718 |
2024-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 069 | −0,01 | 988,66 | −1 977 | 17 864 098 |
2024-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 071 | −0,01 | 984,52 | −1 969 | 17 791 261 |
2024-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 073 | −0,01 | 982,99 | −983 | 17 765 578 |
2024-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 18 074 | −0,02 | 981,95 | −2 946 | 17 747 764 |
2024-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 18 077 | −0,02 | 980,16 | −2 940 | 17 718 352 |
2024-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 080 | −0,01 | 979,40 | −1 959 | 17 707 552 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 082 | −0,01 | 913,21 | −913 | 16 512 663 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 083 | −0,01 | 912,29 | −912 | 16 496 940 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 18 084 | −0,02 | 911,39 | −3 646 | 16 481 577 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 18 088 | −0,03 | 910,47 | −5 463 | 16 468 581 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 18 094 | −0,02 | 909,49 | −3 638 | 16 456 312 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 098 | −0,01 | 907,54 | −1 815 | 16 424 659 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 18 100 | −0,02 | 906,26 | −3 625 | 16 403 306 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 104 | −0,01 | 905,50 | −1 811 | 16 393 172 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 106 | −0,01 | 904,80 | −905 | 16 382 309 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 107 | −0,01 | 903,35 | −903 | 16 356 958 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 108 | −0,01 | 902,66 | −903 | 16 345 367 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 18 109 | −0,02 | 901,41 | −3 606 | 16 323 634 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 18 113 | −0,03 | 900,45 | −4 502 | 16 309 851 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 18 118 | −0,04 | 899,37 | −6 296 | 16 294 786 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −17 | 18 125 | −0,09 | 898,51 | −15 275 | 16 285 494 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 18 142 | −0,05 | 897,68 | −8 079 | 16 285 711 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 18 151 | −0,02 | 896,59 | −2 690 | 16 274 005 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 154 | −0,01 | 895,38 | −1 791 | 16 254 729 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 18 156 | −0,03 | 893,16 | −4 466 | 16 216 213 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 18 161 | −0,05 | 892,50 | −8 032 | 16 208 692 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 18 170 | −0,04 | 891,52 | −6 241 | 16 198 918 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 177 | −0,01 | 890,75 | −1 782 | 16 191 163 |
2024-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 18 179 | −0,02 | 889,50 | −2 668 | 16 170 220 |
2024-04-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −13 | 18 182 | −0,07 | 965,35 | −12 550 | 17 551 994 |
2024-04-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −16 | 18 195 | −0,09 | 964,45 | −15 431 | 17 548 168 |
2024-04-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −20 | 18 211 | −0,11 | 963,60 | −19 272 | 17 548 120 |
2024-04-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 18 231 | −0,05 | 962,42 | −8 662 | 17 545 879 |
2024-04-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −14 | 18 240 | −0,08 | 961,59 | −13 462 | 17 539 402 |
2024-04-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −15 | 18 254 | −0,08 | 960,53 | −14 408 | 17 533 515 |
2024-04-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 18 269 | −0,05 | 959,47 | −8 635 | 17 528 557 |
2024-04-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 278 | −0,01 | 958,86 | −1 918 | 17 526 043 |
2024-04-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 280 | −0,01 | 957,78 | −1 916 | 17 508 218 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 282 | −0,01 | 988,30 | −988 | 18 068 101 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 18 283 | −0,02 | 987,33 | −3 949 | 18 051 354 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 | 18 287 | −0,04 | 986,58 | −7 893 | 18 041 588 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 18 295 | −0,05 | 985,76 | −9 858 | 18 034 479 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −19 | 18 305 | −0,10 | 984,45 | −18 705 | 18 020 357 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 18 324 | −0,07 | 983,61 | −11 803 | 18 023 670 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 | 18 336 | −0,06 | 982,67 | −10 809 | 18 018 237 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −15 | 18 347 | −0,08 | 981,64 | −14 725 | 18 010 149 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 362 | −0,01 | 980,21 | −980 | 17 998 616 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 363 | −0,01 | 979,87 | −980 | 17 993 353 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 364 | −0,01 | 978,09 | −978 | 17 961 645 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 365 | −0,01 | 977,27 | −1 955 | 17 947 564 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 367 | −0,01 | 976,81 | −1 954 | 17 941 069 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 369 | −0,01 | 975,70 | −1 951 | 17 922 633 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 371 | −0,01 | 974,78 | −975 | 17 907 683 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 372 | −0,01 | 972,29 | −1 945 | 17 862 912 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 374 | −0,01 | 971,75 | −972 | 17 854 934 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 18 375 | −0,02 | 970,38 | −3 882 | 17 830 732 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 379 | −0,01 | 969,18 | −969 | 17 812 559 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 380 | −0,01 | 968,66 | −969 | 17 803 971 |
2024-03-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 381 | −0,01 | 967,50 | −968 | 17 783 618 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 18 382 | −0,02 | 963,73 | −3 855 | 17 715 285 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 18 386 | −0,03 | 962,49 | −5 775 | 17 696 341 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 18 392 | −0,02 | 961,37 | −3 845 | 17 681 517 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 18 396 | −0,05 | 960,52 | −9 605 | 17 669 726 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 | 18 406 | −0,04 | 959,68 | −7 677 | 17 663 870 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 18 414 | −0,03 | 958,65 | −4 793 | 17 652 581 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 18 419 | −0,02 | 957,75 | −2 873 | 17 640 797 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 18 422 | −0,04 | 956,21 | −6 693 | 17 615 301 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 18 429 | −0,05 | 955,35 | −9 554 | 17 606 145 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 18 439 | −0,03 | 954,52 | −4 773 | 17 600 394 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 18 444 | −0,02 | 953,18 | −2 860 | 17 580 452 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 18 447 | −0,02 | 951,40 | −2 854 | 17 550 476 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 450 | −0,01 | 950,01 | −1 900 | 17 527 684 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 18 452 | −0,05 | 949,48 | −9 495 | 17 519 805 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 462 | −0,01 | 948,77 | −949 | 17 516 192 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 18 463 | −0,02 | 947,37 | −2 842 | 17 491 292 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 466 | −0,01 | 944,66 | −945 | 17 444 092 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 18 467 | −0,02 | 943,54 | −2 831 | 17 424 353 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 18 470 | −0,03 | 942,50 | −4 712 | 17 407 975 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 18 475 | −0,03 | 941,91 | −5 651 | 17 401 787 |
2024-02-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 481 | −0,01 | 939,53 | −940 | 17 363 454 |
2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 135 | 18 482 | 0,74 | ||||
2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 18 347 | −0,02 | 904,49 | −2 713 | 16 594 678 |
2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −13 | 18 350 | −0,07 | 903,49 | −11 745 | 16 579 042 |
2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 18 363 | −0,05 | 902,37 | −9 024 | 16 570 220 |
2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 18 373 | −0,05 | 901,46 | −8 113 | 16 562 525 |
2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −29 | 18 382 | −0,16 | 900,59 | −26 117 | 16 554 645 |
2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −14 | 18 411 | −0,08 | 899,66 | −12 595 | 16 563 640 |
2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 18 425 | −0,03 | 898,76 | −5 393 | 16 559 653 |
2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 18 431 | −0,02 | 897,41 | −2 692 | 16 540 164 |
2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 | 18 434 | −0,04 | 896,47 | −7 172 | 16 525 528 |
2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 442 | −0,01 | 892,00 | −892 | 16 450 264 |
2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 443 | −0,01 | 887,13 | −887 | 16 361 339 |
2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 444 | −0,01 | 886,26 | −1 773 | 16 346 179 |
2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 446 | −0,01 | 873,91 | −874 | 16 120 144 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 447 | −0,01 | 827,61 | −1 655 | 15 266 922 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 18 449 | −0,05 | 826,62 | −8 266 | 15 250 312 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 459 | −0,01 | 825,38 | −1 651 | 15 235 689 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 18 461 | −0,02 | 824,66 | −2 474 | 15 224 048 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 18 464 | −0,03 | 823,36 | −4 940 | 15 202 519 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 470 | −0,01 | 822,49 | −822 | 15 191 390 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 471 | −0,01 | 821,92 | −1 644 | 15 181 684 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 18 473 | −0,05 | 820,50 | −7 384 | 15 157 096 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 18 482 | −0,04 | 819,62 | −5 737 | 15 148 217 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 489 | −0,01 | 818,76 | −1 638 | 15 138 054 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 18 491 | −0,03 | 817,52 | −4 905 | 15 116 762 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 18 497 | −0,02 | 816,52 | −3 266 | 15 103 170 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 18 501 | −0,02 | 815,46 | −2 446 | 15 086 825 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 504 | −0,01 | 814,78 | −815 | 15 076 689 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 18 505 | −0,02 | 813,35 | −3 253 | 15 051 042 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 18 509 | −0,02 | 812,58 | −2 438 | 15 040 043 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −27 | 18 512 | −0,15 | 811,48 | −21 910 | 15 022 118 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 18 539 | −0,04 | 810,77 | −5 675 | 15 030 865 |
2023-12-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 546 | −0,01 | 809,03 | −809 | 15 004 270 |
2023-11-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 547 | −0,01 | 838,46 | −838 | 15 550 918 |
2023-11-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 18 548 | −0,02 | 830,39 | −2 491 | 15 402 074 |
2023-11-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −18 | 18 551 | −0,10 | 829,43 | −14 930 | 15 386 756 |
2023-11-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −39 | 18 569 | −0,21 | 828,54 | −32 313 | 15 385 159 |
2023-11-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 | 18 608 | −0,06 | 827,65 | −9 104 | 15 400 911 |
2023-11-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 18 619 | −0,02 | 826,58 | −3 306 | 15 390 093 |
2023-11-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −18 | 18 623 | −0,10 | 825,53 | −14 860 | 15 373 845 |
2023-11-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 18 641 | −0,03 | 824,59 | −4 948 | 15 371 182 |
2023-08-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 647 | −0,01 | 744,66 | −745 | 13 885 675 |
2023-08-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 648 | −0,01 | 741,42 | −1 483 | 13 826 000 |
2023-08-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 18 650 | −0,02 | 740,52 | −2 222 | 13 810 698 |
2023-08-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 18 653 | −0,03 | 739,63 | −3 698 | 13 796 318 |
2023-08-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 18 658 | −0,05 | 738,45 | −7 384 | 13 778 000 |
2023-08-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −17 | 18 668 | −0,09 | 737,50 | −12 538 | 13 767 650 |
2023-08-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −16 | 18 685 | −0,09 | 736,64 | −11 786 | 13 764 118 |
2023-08-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −22 | 18 701 | −0,12 | 735,55 | −16 182 | 13 755 521 |
2023-08-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −18 | 18 723 | −0,10 | 734,56 | −13 222 | 13 753 167 |
2023-08-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 18 741 | −0,02 | 733,51 | −2 934 | 13 746 711 |
2023-08-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 745 | −0,01 | 732,76 | −1 466 | 13 735 586 |
2023-07-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 747 | −0,01 | 720,15 | −720 | 13 500 652 |
2023-07-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 | 18 748 | −0,06 | 719,36 | −7 913 | 13 486 561 |
2023-07-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 18 759 | −0,06 | 718,71 | −8 625 | 13 482 281 |
2023-07-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −22 | 18 771 | −0,12 | 717,57 | −15 787 | 13 469 506 |
2023-07-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −29 | 18 793 | −0,15 | 716,74 | −20 785 | 13 469 695 |
2023-07-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 18 822 | −0,04 | 715,23 | −5 007 | 13 462 059 |
2023-07-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 18 829 | −0,05 | 714,65 | −7 146 | 13 456 145 |
2023-07-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 18 839 | −0,03 | 713,82 | −4 283 | 13 447 655 |
2023-07-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 845 | −0,01 | 711,95 | −712 | 13 416 698 |
2023-07-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 18 846 | −0,01 | 710,09 | −710 | 13 382 356 |
2023-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 18 847 | −0,04 | 738,35 | −5 168 | 13 915 682 |
2023-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −17 | 18 854 | −0,09 | 737,52 | −12 538 | 13 905 202 |
2023-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −31 | 18 871 | −0,16 | 736,40 | −22 828 | 13 896 604 |
2023-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 18 902 | −0,06 | 735,42 | −8 825 | 13 900 909 |
2023-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 18 914 | −0,05 | 734,62 | −7 346 | 13 894 603 |
2023-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 924 | −0,01 | 733,61 | −1 467 | 13 882 836 |
2023-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 18 926 | −0,05 | 732,49 | −7 325 | 13 863 106 |
2023-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 18 936 | −0,05 | 731,49 | −6 583 | 13 851 495 |
2023-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 945 | −0,01 | 730,03 | −1 460 | 13 830 418 |
2023-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −15 | 18 947 | −0,08 | 808,11 | −12 122 | 15 311 260 |
2023-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −17 | 18 962 | −0,09 | 807,50 | −13 728 | 15 311 815 |
2023-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −15 | 18 979 | −0,08 | 806,53 | −12 098 | 15 307 133 |
2023-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 18 994 | −0,03 | 805,34 | −4 027 | 15 296 628 |
2023-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 18 999 | −0,01 | 804,51 | −1 609 | 15 284 885 |
2023-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −30 | 19 001 | −0,16 | 803,58 | −24 107 | 15 268 824 |
2023-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −16 | 19 031 | −0,08 | 802,67 | −12 843 | 15 275 613 |
2023-04-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 19 047 | −0,03 | 823,34 | −4 940 | 15 682 157 |
2023-04-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 19 053 | −0,05 | 822,37 | −7 401 | 15 668 616 |
2023-04-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 19 062 | −0,01 | 821,61 | −822 | 15 661 530 |
2023-04-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 19 063 | −0,03 | 820,55 | −4 103 | 15 642 145 |
2023-04-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −32 | 19 068 | −0,17 | 819,48 | −26 223 | 15 625 845 |
2023-04-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −27 | 19 100 | −0,14 | 818,47 | −22 099 | 15 632 777 |
2023-04-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −13 | 19 127 | −0,07 | 817,49 | −10 627 | 15 636 131 |
2023-04-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 19 140 | −0,04 | 816,58 | −5 716 | 15 629 341 |
2023-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 19 147 | −0,04 | 766,32 | −5 364 | 14 672 729 |
2023-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 19 154 | −0,05 | 765,55 | −7 656 | 14 663 345 |
2023-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −17 | 19 164 | −0,09 | 764,49 | −12 996 | 14 650 686 |
2023-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 | 19 181 | −0,06 | 763,51 | −8 399 | 14 644 885 |
2023-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 19 192 | −0,05 | 762,28 | −6 861 | 14 629 678 |
2023-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −16 | 19 201 | −0,08 | 761,62 | −12 186 | 14 623 866 |
2023-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 19 217 | −0,05 | 760,54 | −7 605 | 14 615 297 |
2023-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −15 | 19 227 | −0,08 | 759,48 | −11 392 | 14 602 522 |
2023-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 19 242 | −0,03 | 758,20 | −3 791 | 14 589 284 |
2023-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 19 247 | −0,01 | 762,17 | −1 524 | 14 669 486 |
2023-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 19 249 | −0,02 | 761,58 | −2 285 | 14 659 653 |
2023-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 19 252 | −0,02 | 760,40 | −3 042 | 14 639 221 |
2023-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 19 256 | −0,02 | 759,65 | −3 039 | 14 627 820 |
2023-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 19 260 | −0,04 | 758,58 | −5 310 | 14 610 251 |
2023-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 19 267 | −0,01 | 757,29 | −1 515 | 14 590 706 |
2023-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −24 | 19 269 | −0,12 | 756,77 | −18 162 | 14 582 201 |
2023-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −17 | 19 293 | −0,09 | 755,50 | −12 844 | 14 575 862 |
2023-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −17 | 19 310 | −0,09 | 754,45 | −12 826 | 14 568 430 |
2023-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −18 | 19 327 | −0,09 | 753,54 | −13 564 | 14 563 668 |
2023-02-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 19 345 | −0,01 | 752,11 | −1 504 | 14 549 568 |
2023-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 165 | 19 347 | 0,86 | ||||
2023-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 19 182 | −0,01 | 732,18 | −1 464 | 14 044 677 |
2023-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 19 184 | −0,06 | 731,59 | −8 779 | 14 034 823 |
2023-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 19 196 | −0,02 | 730,35 | −2 921 | 14 019 799 |
2023-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 19 200 | −0,01 | 729,92 | −730 | 14 014 464 |
2023-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 | 19 201 | −0,06 | 728,34 | −8 012 | 13 984 856 |
2023-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −13 | 19 212 | −0,07 | 727,59 | −9 459 | 13 978 459 |
2023-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 19 225 | −0,05 | 726,34 | −7 263 | 13 963 886 |
2023-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 19 235 | −0,05 | 725,63 | −6 531 | 13 957 493 |
2023-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 19 244 | −0,05 | 724,52 | −6 521 | 13 942 663 |
2023-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 19 253 | −0,05 | 723,52 | −7 235 | 13 929 931 |
2023-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 19 263 | −0,03 | 722,59 | −3 613 | 13 919 251 |
2023-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −14 | 19 268 | −0,07 | 721,48 | −10 101 | 13 901 477 |
2022-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 19 282 | −0,03 | 767,44 | −4 605 | 14 797 778 |
2022-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 19 288 | −0,03 | 766,39 | −4 598 | 14 782 130 |
2022-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 19 294 | −0,02 | 765,70 | −2 297 | 14 773 416 |
2022-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 19 297 | −0,01 | 764,61 | −1 529 | 14 754 679 |
2022-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 19 299 | −0,02 | 763,28 | −2 290 | 14 730 541 |
2022-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 19 302 | −0,01 | 762,57 | −763 | 14 719 126 |
2022-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 19 303 | −0,03 | 761,56 | −4 569 | 14 700 393 |
2022-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 19 309 | −0,01 | 759,67 | −1 519 | 14 668 468 |
2022-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 19 311 | −0,02 | 758,39 | −2 275 | 14 645 269 |
2022-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 19 314 | −0,03 | 757,60 | −3 788 | 14 632 286 |
2022-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −20 | 19 319 | −0,10 | 756,35 | −15 127 | 14 611 926 |
2022-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −26 | 19 339 | −0,13 | 755,47 | −19 642 | 14 610 034 |
2022-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 19 365 | −0,04 | 754,61 | −5 282 | 14 613 023 |
2022-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 19 372 | −0,04 | 753,53 | −5 275 | 14 597 383 |
2022-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 19 379 | −0,02 | 752,57 | −2 258 | 14 584 054 |
2022-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 19 382 | −0,01 | 761,00 | −1 522 | 14 749 702 |
2022-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 19 384 | −0,03 | 759,61 | −3 798 | 14 724 280 |
2022-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 19 389 | −0,02 | 758,16 | −3 033 | 14 699 964 |
2022-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −15 | 19 393 | −0,08 | 757,58 | −11 364 | 14 691 749 |
2022-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −26 | 19 408 | −0,13 | 756,31 | −19 664 | 14 678 464 |
2022-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −18 | 19 434 | −0,09 | 755,50 | −13 599 | 14 682 387 |
2022-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 19 452 | −0,06 | 754,73 | −9 057 | 14 681 008 |
2022-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 19 464 | −0,05 | 753,68 | −7 537 | 14 669 628 |
2022-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 19 474 | −0,03 | 752,59 | −4 516 | 14 655 938 |
2022-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 19 480 | −0,01 | 750,00 | −1 500 | 14 610 000 |
2022-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −24 | 19 482 | −0,12 | 733,64 | −17 607 | 14 292 774 |
2022-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 19 506 | −0,04 | 732,47 | −5 127 | 14 287 560 |
2022-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 19 513 | −0,03 | 731,49 | −4 389 | 14 273 564 |
2022-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 19 519 | −0,01 | 730,00 | −1 460 | 14 248 870 |
2022-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −19 | 19 521 | −0,10 | 728,23 | −13 836 | 14 215 778 |
2022-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −18 | 19 540 | −0,09 | 727,52 | −13 095 | 14 215 741 |
2022-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 19 558 | −0,01 | 726,03 | −726 | 14 199 695 |
2022-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 19 559 | −0,02 | 718,48 | −2 155 | 14 052 750 |
2022-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 19 562 | −0,01 | 717,87 | −1 436 | 14 042 973 |
2022-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 19 564 | −0,03 | 715,94 | −4 296 | 14 006 650 |
2022-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 19 570 | −0,01 | 714,08 | −1 428 | 13 974 546 |
2022-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 19 572 | −0,03 | 711,00 | −3 555 | 13 915 692 |
2022-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 19 577 | −0,02 | 710,73 | −2 132 | 13 913 961 |
2022-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 19 580 | −0,01 | 705,39 | −1 411 | 13 811 536 |
2022-09-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 19 582 | −0,02 | 587,23 | −1 762 | 11 499 138 |
2022-09-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 | 19 585 | −0,04 | 586,31 | −4 690 | 11 482 881 |
2022-09-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −16 | 19 593 | −0,08 | 585,58 | −9 369 | 11 473 269 |
2022-09-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 19 609 | −0,03 | 584,77 | −3 509 | 11 466 755 |
2022-09-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 | 19 615 | −0,06 | 583,45 | −6 418 | 11 444 372 |
2022-09-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 | 19 626 | −0,04 | 582,51 | −4 660 | 11 432 341 |
2022-09-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −14 | 19 634 | −0,07 | 581,46 | −8 140 | 11 416 386 |
2022-09-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 19 648 | −0,05 | 580,75 | −5 227 | 11 410 576 |
2022-09-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 19 657 | −0,04 | 579,67 | −4 058 | 11 394 573 |
2022-09-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 | 19 664 | −0,06 | 578,56 | −6 364 | 11 376 804 |
2022-09-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 19 675 | −0,02 | 577,26 | −2 309 | 11 357 590 |
2022-09-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 19 679 | −0,02 | 576,85 | −1 731 | 11 351 831 |
2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −1 410 | 19 682 | −6,68 | 622,06 | −877 105 | 12 243 385 | |
2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 2 479 | 21 092 | 13,32 | 380,95 | 944 375 | 8 034 997 | |
2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −4 156 | 18 613 | −18,25 | 621,54 | −2 583 120 | 11 568 724 | |
2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 4 361 | 22 769 | 23,69 | 374,12 | 1 631 537 | 8 518 338 | |
2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −4 887 | 18 408 | −20,98 | 620,85 | −3 034 094 | 11 428 607 | |
2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 3 613 | 23 295 | 18,36 | 482,68 | 1 743 923 | 11 244 031 | |
2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −2 500 | 19 682 | −11,27 | ||||
2022-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 22 182 | −0,01 | 658,09 | −1 974 | 14 597 752 |
2022-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 22 185 | −0,01 | 656,97 | −1 971 | 14 574 879 |
2022-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 22 188 | −0,03 | 655,44 | −3 933 | 14 542 903 |
2022-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 22 194 | 0,00 | 654,21 | −654 | 14 519 537 |
2022-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −21 | 22 195 | −0,09 | 653,57 | −13 725 | 14 505 986 |
2022-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −14 | 22 216 | −0,06 | 652,71 | −9 138 | 14 500 605 |
2022-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 22 230 | −0,04 | 651,46 | −6 515 | 14 481 956 |
2022-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 22 240 | −0,03 | 650,47 | −3 903 | 14 466 453 |
2022-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 22 246 | −0,02 | 649,62 | −3 248 | 14 451 447 |
2022-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 22 251 | −0,02 | 648,68 | −2 595 | 14 433 779 |
2022-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 22 255 | −0,01 | 647,09 | −1 941 | 14 400 988 |
2022-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 22 258 | −0,03 | 646,49 | −4 525 | 14 389 574 |
2022-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 22 265 | −0,01 | 645,64 | −1 937 | 14 375 175 |
2022-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 22 268 | −0,04 | 644,54 | −5 801 | 14 352 617 |
2022-05-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 22 277 | −0,02 | 643,76 | −3 219 | 14 341 042 |
2022-04-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 22 282 | −0,01 | 701,82 | −2 105 | 15 637 953 |
2022-04-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 22 285 | −0,02 | 698,14 | −2 793 | 15 558 050 |
2022-04-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 22 289 | −0,03 | 697,39 | −4 882 | 15 544 126 |
2022-04-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 | 22 296 | −0,04 | 696,50 | −5 572 | 15 529 164 |
2022-04-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −14 | 22 304 | −0,06 | 695,46 | −9 736 | 15 511 540 |
2022-04-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 22 318 | −0,02 | 694,74 | −2 779 | 15 505 207 |
2022-04-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 22 322 | −0,02 | 693,69 | −2 775 | 15 484 548 |
2022-04-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 22 326 | −0,04 | 692,41 | −6 924 | 15 458 746 |
2022-04-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 22 336 | −0,04 | 691,34 | −6 913 | 15 441 770 |
2022-04-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 22 346 | −0,05 | 690,59 | −8 287 | 15 431 924 |
2022-04-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 22 358 | −0,01 | 689,42 | −2 068 | 15 414 052 |
2022-04-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 22 361 | −0,05 | 688,59 | −8 263 | 15 397 561 |
2022-04-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 22 373 | −0,01 | 687,45 | −2 062 | 15 380 319 |
2022-04-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 22 376 | −0,03 | 686,83 | −4 121 | 15 368 508 |
2022-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −13 | 22 382 | −0,06 | 623,23 | −8 102 | 13 949 134 |
2022-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −21 | 22 395 | −0,09 | 622,49 | −13 072 | 13 940 664 |
2022-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 | 22 416 | −0,04 | 621,43 | −4 971 | 13 929 975 |
2022-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 22 424 | −0,03 | 620,55 | −3 723 | 13 915 213 |
2022-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 22 430 | −0,03 | 619,40 | −4 336 | 13 893 142 |
2022-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 22 437 | −0,01 | 618,34 | −1 855 | 13 873 695 |
2022-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 22 440 | −0,04 | 617,66 | −5 559 | 13 860 290 |
2022-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 22 449 | −0,03 | 616,55 | −4 316 | 13 840 931 |
2022-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 22 456 | −0,01 | 615,45 | −1 846 | 13 820 545 |
2022-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 22 459 | −0,02 | 614,38 | −2 458 | 13 798 360 |
2022-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 22 463 | −0,01 | 613,82 | −1 228 | 13 788 239 |
2022-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 22 465 | −0,01 | 612,45 | −1 837 | 13 758 689 |
2022-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 22 468 | −0,01 | 611,04 | −1 833 | 13 728 847 |
2022-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 22 471 | −0,01 | 610,83 | −1 832 | 13 725 961 |
2022-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 22 474 | −0,01 | 609,61 | −1 829 | 13 700 375 |
2022-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 22 477 | −0,01 | 608,48 | −1 217 | 13 676 805 |
2022-03-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 22 479 | −0,01 | 607,28 | −1 822 | 13 651 047 |
2022-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 22 482 | −0,02 | 611,33 | −3 057 | 13 743 921 |
2022-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 22 487 | −0,02 | 610,17 | −3 051 | 13 720 893 |
2022-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −36 | 22 492 | −0,16 | 609,50 | −21 942 | 13 708 874 |
2022-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 22 528 | 0,00 | 608,74 | −609 | 13 713 695 |
2022-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 22 529 | −0,01 | 607,56 | −1 823 | 13 687 719 |
2022-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −20 | 22 532 | −0,09 | 606,74 | −12 135 | 13 671 066 |
2022-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 22 552 | −0,03 | 605,50 | −4 238 | 13 655 236 |
2022-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 22 559 | 0,00 | 604,26 | −604 | 13 631 501 |
2022-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 22 560 | −0,03 | 603,61 | −3 622 | 13 617 442 |
2022-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −13 | 22 566 | −0,06 | 602,35 | −7 831 | 13 592 630 |
2022-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 22 579 | 0,00 | 601,79 | −602 | 13 587 816 |
2022-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 22 580 | −0,01 | 600,89 | −1 202 | 13 568 096 |
2022-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 2 707 | 2 707 | |||||
2022-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 191 | 22 582 | 0,85 | ||||
2022-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 22 391 | −0,01 | 628,87 | −1 258 | 14 081 028 |
2022-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 22 393 | −0,03 | 627,22 | −3 763 | 14 045 337 |
2022-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 22 399 | −0,02 | 626,48 | −3 132 | 14 032 526 |
2022-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −45 | 22 404 | −0,20 | 625,56 | −28 150 | 14 015 046 |
2022-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −14 | 22 449 | −0,06 | 624,30 | −8 740 | 14 014 911 |
2022-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −19 | 22 463 | −0,08 | 623,62 | −11 849 | 14 008 376 |
2022-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 | 22 482 | −0,04 | 622,52 | −4 980 | 13 995 495 |
2022-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 22 490 | 0,00 | 621,98 | −622 | 13 988 330 |
2021-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 22 491 | −0,03 | 641,23 | −3 847 | 14 421 904 |
2021-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 22 497 | −0,02 | 640,47 | −3 202 | 14 408 654 |
2021-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −24 | 22 502 | −0,11 | 639,49 | −15 348 | 14 389 804 |
2021-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 22 526 | −0,05 | 638,62 | −7 663 | 14 385 554 |
2021-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −22 | 22 538 | −0,10 | 637,75 | −14 030 | 14 373 610 |
2021-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 22 560 | 0,00 | 636,50 | −636 | 14 359 440 |
2021-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 22 561 | −0,04 | 635,36 | −5 718 | 14 334 357 |
2021-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 | 22 570 | −0,05 | 634,56 | −6 980 | 14 322 019 |
2021-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 22 581 | −0,01 | 633,47 | −1 267 | 14 304 386 |
2021-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 22 583 | −0,03 | 632,63 | −4 428 | 14 286 683 |
2021-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 22 590 | 0,00 | 631,15 | −631 | 14 257 678 |
2021-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −500 | 22 591 | −2,17 | ||||
2021-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 | 23 091 | −0,03 | 647,00 | −5 176 | 14 939 877 |
2021-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 23 099 | −0,02 | 646,37 | −3 232 | 14 930 501 |
2021-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −15 | 23 104 | −0,06 | 645,41 | −9 681 | 14 911 553 |
2021-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 23 119 | −0,04 | 644,62 | −5 802 | 14 902 970 |
2021-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 23 128 | 0,00 | 643,82 | −644 | 14 890 269 |
2021-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 23 129 | −0,04 | 642,28 | −5 781 | 14 855 294 |
2021-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −19 | 23 138 | −0,08 | 641,52 | −12 189 | 14 843 490 |
2021-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −17 | 23 157 | −0,07 | 640,08 | −10 881 | 14 822 333 |
2021-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 | 23 174 | −0,05 | 639,52 | −7 035 | 14 820 236 |
2021-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 23 185 | −0,03 | 638,62 | −3 832 | 14 806 405 |
2021-10-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 23 191 | −0,01 | 577,27 | −1 155 | 13 387 469 |
2021-10-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 23 193 | −0,05 | 576,34 | −6 916 | 13 367 054 |
2021-10-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 23 205 | −0,02 | 575,41 | −2 302 | 13 352 389 |
2021-10-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 23 209 | −0,02 | 574,33 | −2 872 | 13 329 625 |
2021-10-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 23 214 | −0,03 | 573,54 | −4 015 | 13 314 158 |
2021-10-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 23 221 | 0,00 | 572,32 | −572 | 13 289 843 |
2021-10-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 23 222 | −0,01 | 571,88 | −1 144 | 13 280 197 |
2021-10-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 23 224 | −0,04 | 570,37 | −5 133 | 13 246 273 |
2021-10-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −15 | 23 233 | −0,06 | 569,54 | −8 543 | 13 232 123 |
2021-10-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 23 248 | 0,00 | 568,03 | −568 | 13 205 561 |
2021-10-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 23 249 | 0,00 | 567,99 | −568 | 13 205 200 |
2021-10-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 23 250 | −0,04 | 566,65 | −5 666 | 13 174 612 |
2021-10-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 | 23 260 | −0,05 | 565,36 | −6 219 | 13 150 274 |
2021-10-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 23 271 | −0,05 | 564,47 | −6 774 | 13 135 781 |
2021-10-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 23 283 | −0,01 | 563,84 | −1 692 | 13 127 887 |
2021-10-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 23 286 | −0,02 | 562,68 | −2 251 | 13 102 566 |
2021-10-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 23 290 | 0,00 | 560,51 | −561 | 13 054 278 |
2021-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 23 291 | −0,01 | 684,31 | −1 369 | 15 938 264 |
2021-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 23 293 | 0,00 | 683,79 | −684 | 15 927 520 |
2021-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 23 294 | −0,02 | 682,32 | −2 729 | 15 893 962 |
2021-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 23 298 | −0,01 | 681,48 | −1 363 | 15 877 121 |
2021-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 23 300 | −0,02 | 680,53 | −2 722 | 15 856 349 |
2021-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 23 304 | −0,01 | 679,55 | −2 039 | 15 836 233 |
2021-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 23 307 | −0,04 | 678,43 | −6 784 | 15 812 168 |
2021-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 23 317 | −0,01 | 677,70 | −2 033 | 15 801 931 |
2021-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −21 | 23 320 | −0,09 | 676,54 | −14 207 | 15 776 913 |
2021-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 23 341 | −0,03 | 675,70 | −4 730 | 15 771 514 |
2021-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −14 | 23 348 | −0,06 | 674,51 | −9 443 | 15 748 459 |
2021-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −19 | 23 362 | −0,08 | 673,56 | −12 798 | 15 735 709 |
2021-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 23 381 | −0,04 | 672,75 | −6 728 | 15 729 568 |
2021-08-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 23 391 | −0,01 | 580,33 | −1 741 | 13 574 499 |
2021-08-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −39 | 23 394 | −0,17 | 579,35 | −22 595 | 13 553 314 |
2021-08-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −28 | 23 433 | −0,12 | 578,67 | −16 203 | 13 559 974 |
2021-08-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 23 461 | −0,02 | 577,42 | −2 887 | 13 546 851 |
2021-08-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 23 466 | −0,01 | 576,51 | −1 730 | 13 528 384 |
2021-08-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 23 469 | −0,02 | 575,24 | −2 876 | 13 500 308 |
2021-08-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −13 | 23 474 | −0,06 | 574,70 | −7 471 | 13 490 508 |
2021-08-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 23 487 | −0,01 | 573,20 | −1 146 | 13 462 748 |
2021-08-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 23 489 | −0,01 | 572,94 | −1 146 | 13 457 788 |
2021-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −13 | 23 491 | −0,06 | 568,43 | −7 390 | 13 352 989 |
2021-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −13 | 23 504 | −0,06 | 567,56 | −7 378 | 13 339 930 |
2021-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 23 517 | −0,05 | 566,42 | −6 797 | 13 320 499 |
2021-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −13 | 23 529 | −0,06 | 565,44 | −7 351 | 13 304 238 |
2021-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 23 542 | −0,03 | 564,71 | −3 388 | 13 294 403 |
2021-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −16 | 23 548 | −0,07 | 563,40 | −9 014 | 13 266 943 |
2021-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 23 564 | −0,04 | 562,48 | −5 625 | 13 254 279 |
2021-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 23 574 | −0,03 | 561,80 | −3 371 | 13 243 873 |
2021-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 23 580 | −0,01 | 560,62 | −1 121 | 13 219 420 |
2021-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 23 582 | −0,01 | 559,78 | −1 120 | 13 200 732 |
2021-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 23 584 | 0,00 | 557,75 | −558 | 13 153 976 |
2021-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 23 585 | −0,02 | 556,71 | −2 227 | 13 130 005 |
2021-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 23 589 | −0,01 | 555,47 | −1 111 | 13 102 982 |
2021-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 23 591 | −0,01 | 528,37 | −1 057 | 12 464 777 |
2021-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 23 593 | −0,05 | 527,63 | −6 332 | 12 448 375 |
2021-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 23 605 | −0,04 | 526,48 | −5 265 | 12 427 560 |
2021-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −15 | 23 615 | −0,06 | 525,63 | −7 884 | 12 412 752 |
2021-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −23 | 23 630 | −0,10 | 524,49 | −12 063 | 12 393 699 |
2021-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −20 | 23 653 | −0,08 | 523,59 | −10 472 | 12 384 474 |
2021-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −18 | 23 673 | −0,08 | 522,41 | −9 403 | 12 367 012 |
2021-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 23 691 | −0,01 | 512,82 | −1 026 | 12 149 219 |
2021-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 23 693 | −0,02 | 509,28 | −2 037 | 12 066 371 |
2021-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −16 | 23 697 | −0,07 | 508,52 | −8 136 | 12 050 398 |
2021-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −22 | 23 713 | −0,09 | 507,39 | −11 163 | 12 031 739 |
2021-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −30 | 23 735 | −0,13 | 506,44 | −15 193 | 12 020 353 |
2021-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −17 | 23 765 | −0,07 | 505,60 | −8 595 | 12 015 584 |
2021-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 23 782 | −0,04 | 504,68 | −4 542 | 12 002 300 |
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 3 613 | 3 613 | |||||
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 248 | 23 791 | 1,05 | ||||
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 23 543 | 0,00 | 491,36 | −491 | 11 568 088 |
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 23 544 | −0,02 | 490,69 | −1 963 | 11 552 805 |
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 23 548 | −0,01 | 489,41 | −979 | 11 524 627 |
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 23 550 | −0,02 | 488,26 | −2 441 | 11 498 523 |
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 23 555 | −0,02 | 487,63 | −2 438 | 11 486 125 |
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 23 560 | −0,02 | 486,77 | −2 434 | 11 468 301 |
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 23 565 | −0,05 | 485,50 | −5 826 | 11 440 808 |
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 23 577 | −0,03 | 484,79 | −3 394 | 11 429 894 |
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 23 584 | −0,04 | 483,37 | −4 350 | 11 399 798 |
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −13 | 23 593 | −0,06 | 482,30 | −6 270 | 11 378 904 |
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −13 | 23 606 | −0,06 | 481,48 | −6 259 | 11 365 817 |
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −14 | 23 619 | −0,06 | 480,57 | −6 728 | 11 350 583 |
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 23 633 | −0,02 | 479,54 | −2 398 | 11 332 969 |
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 23 638 | 0,00 | 478,89 | −479 | 11 320 002 |
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 23 639 | −0,02 | 477,58 | −1 910 | 11 289 514 |
2020-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 23 643 | −0,01 | 524,31 | −1 573 | 12 396 261 |
2020-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 23 646 | −0,04 | 523,32 | −5 233 | 12 374 425 |
2020-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −14 | 23 656 | −0,06 | 522,45 | −7 314 | 12 359 077 |
2020-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 23 670 | −0,04 | 521,50 | −5 215 | 12 343 905 |
2020-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −27 | 23 680 | −0,11 | 520,58 | −14 056 | 12 327 334 |
2020-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −13 | 23 707 | −0,05 | 519,60 | −6 755 | 12 318 157 |
2020-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 23 720 | −0,03 | 518,55 | −3 111 | 12 300 006 |
2020-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 | 23 726 | −0,05 | 517,63 | −5 694 | 12 281 289 |
2020-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 23 737 | −0,02 | 516,37 | −2 065 | 12 257 075 |
2020-12-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 23 741 | −0,01 | 515,64 | −1 031 | 12 241 809 |
2020-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 23 743 | −0,04 | 556,02 | −5 560 | 13 201 583 |
2020-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −20 | 23 753 | −0,08 | 552,39 | −11 048 | 13 120 920 |
2020-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −20 | 23 773 | −0,08 | 548,58 | −10 972 | 13 041 392 |
2020-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −20 | 23 793 | −0,08 | 546,40 | −10 928 | 13 000 495 |
2020-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 23 813 | −0,04 | 545,59 | −5 456 | 12 992 135 |
2020-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −20 | 23 823 | −0,08 | 544,54 | −10 891 | 12 972 576 |
2020-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −2 000 | 24 343 | −7,59 | ||||
2020-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −1 000 | 26 323 | −3,66 | ||||
2020-11-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −1 500 | 27 323 | −5,20 | ||||
2020-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 28 343 | −0,01 | 565,22 | −1 130 | 16 020 030 |
2020-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 28 345 | −0,02 | 564,25 | −3 950 | 15 993 666 |
2020-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 28 352 | 0,00 | 563,80 | −564 | 15 984 858 |
2020-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 28 353 | −0,02 | 562,63 | −2 813 | 15 952 248 |
2020-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 28 358 | −0,01 | 561,48 | −2 246 | 15 922 450 |
2020-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 28 362 | −0,02 | 560,41 | −3 362 | 15 894 348 |
2020-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 28 368 | −0,04 | 559,43 | −6 713 | 15 869 910 |
2020-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 | 28 380 | −0,04 | 558,63 | −6 145 | 15 853 919 |
2020-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 28 391 | −0,01 | 557,44 | −1 115 | 15 826 279 |
2020-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 28 393 | −0,04 | 556,50 | −5 565 | 15 800 704 |
2020-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −30 | 28 403 | −0,11 | 555,52 | −16 666 | 15 778 435 |
2020-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 | 28 433 | −0,03 | 554,61 | −4 437 | 15 769 226 |
2020-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 28 441 | −0,01 | 553,73 | −1 107 | 15 748 635 |
2020-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −18 | 28 443 | −0,06 | 591,50 | −10 647 | 16 824 034 |
2020-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 28 461 | −0,01 | 600,30 | −1 201 | 17 085 138 |
2020-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −20 | 28 463 | −0,07 | 601,13 | −12 023 | 17 109 963 |
2020-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 28 483 | −0,04 | 602,33 | −6 023 | 17 156 165 |
2020-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 28 493 | −0,04 | 605,62 | −6 056 | 17 255 931 |
2020-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −20 | 28 503 | −0,07 | 608,69 | −12 174 | 17 349 491 |
2020-09-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −20 | 28 523 | −0,07 | 616,74 | −12 335 | 17 591 275 |
2020-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 28 543 | −0,01 | 647,03 | −1 294 | 18 468 177 |
2020-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −17 | 28 545 | −0,06 | 646,26 | −10 986 | 18 447 492 |
2020-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 28 562 | −0,04 | 645,64 | −7 748 | 18 440 770 |
2020-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 28 574 | −0,02 | 644,34 | −3 866 | 18 411 371 |
2020-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −15 | 28 580 | −0,05 | 643,50 | −9 652 | 18 391 230 |
2020-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 28 595 | −0,02 | 642,51 | −4 498 | 18 372 573 |
2020-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 28 602 | −0,02 | 641,52 | −4 491 | 18 348 755 |
2020-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 28 609 | 0,00 | 640,35 | −640 | 18 319 773 |
2020-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 28 610 | 0,00 | 639,99 | −640 | 18 310 114 |
2020-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 28 611 | −0,04 | 638,51 | −7 662 | 18 268 410 |
2020-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 28 623 | −0,02 | 637,47 | −3 825 | 18 246 304 |
2020-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 28 629 | −0,01 | 636,46 | −2 546 | 18 221 213 |
2020-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 28 633 | −0,01 | 635,52 | −1 271 | 18 196 844 |
2020-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 28 635 | −0,02 | 634,60 | −3 173 | 18 171 771 |
2020-08-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 28 640 | −0,01 | 633,78 | −1 901 | 18 151 459 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 28 643 | −0,01 | 625,00 | −1 250 | 17 901 875 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 28 645 | −0,01 | 624,10 | −1 248 | 17 877 344 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 28 647 | −0,01 | 623,02 | −1 246 | 17 847 654 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 28 649 | 0,00 | 621,79 | −622 | 17 813 662 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 28 650 | −0,02 | 616,16 | −3 081 | 17 652 984 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 28 655 | −0,01 | 615,66 | −1 847 | 17 641 737 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 28 658 | 0,00 | 614,76 | −615 | 17 617 792 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 28 659 | −0,01 | 613,45 | −2 454 | 17 580 864 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 28 663 | −0,01 | 612,65 | −2 451 | 17 560 387 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 | 28 667 | −0,03 | 611,50 | −4 892 | 17 529 870 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 28 675 | −0,02 | 610,48 | −3 052 | 17 505 514 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 28 680 | −0,03 | 609,48 | −5 485 | 17 479 886 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 28 689 | −0,03 | 608,48 | −6 085 | 17 456 683 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 | 28 699 | −0,04 | 607,40 | −6 681 | 17 431 773 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 28 710 | −0,03 | 606,57 | −6 066 | 17 414 625 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 28 720 | −0,01 | 605,41 | −1 816 | 17 387 375 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −13 | 28 723 | −0,05 | 604,45 | −7 858 | 17 361 617 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 28 736 | −0,01 | 603,26 | −1 810 | 17 335 279 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 28 739 | −0,01 | 602,80 | −2 411 | 17 323 869 |
2020-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 28 743 | −0,01 | 607,20 | −1 214 | 17 452 750 |
2020-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −15 | 28 745 | −0,05 | 606,50 | −9 098 | 17 433 842 |
2020-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 28 760 | −0,03 | 605,40 | −5 449 | 17 411 304 |
2020-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −21 | 28 769 | −0,07 | 604,51 | −12 695 | 17 391 148 |
2020-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 | 28 790 | −0,04 | 603,64 | −6 640 | 17 378 796 |
2020-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 28 801 | −0,03 | 602,48 | −6 025 | 17 352 026 |
2020-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 28 811 | −0,03 | 601,56 | −6 016 | 17 331 545 |
2020-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 28 821 | −0,01 | 600,53 | −1 201 | 17 307 875 |
2020-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −15 | 28 823 | −0,05 | 599,59 | −8 994 | 17 281 983 |
2020-06-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 28 838 | −0,02 | 598,58 | −2 993 | 17 261 850 |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −9 212 | 0 | −100,00 | ||||
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 838 | 0 | −100,00 | ||||
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 960 | 2 479 | −66,68 | ||||
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 830 | 0 | −100,00 | ||||
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 784 | 0 | −100,00 | ||||
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 500 | 0 | −100,00 | ||||
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −4 731 | 28 843 | −14,09 | 556,31 | −2 631 903 | 16 045 649 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −1 595 | 33 574 | −4,54 | 555,25 | −885 624 | 18 641 964 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −2 172 | 35 169 | −5,82 | 554,33 | −1 204 005 | 19 495 232 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −5 423 | 37 341 | −12,68 | 553,16 | −2 999 787 | 20 655 548 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −6 477 | 42 764 | −13,15 | 552,33 | −3 577 441 | 23 619 840 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −7 341 | 49 241 | −12,97 | 551,66 | −4 049 736 | 27 164 290 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −7 295 | 56 582 | −11,42 | 550,58 | −4 016 481 | 31 152 918 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −4 113 | 63 877 | −6,05 | 549,35 | −2 259 477 | 35 090 830 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −2 597 | 67 990 | −3,68 | 548,17 | −1 423 597 | 37 270 078 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −1 597 | 70 587 | −2,21 | 547,37 | −874 150 | 38 637 206 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −1 631 | 72 184 | −2,21 | 546,31 | −891 032 | 39 434 841 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −1 390 | 73 815 | −1,85 | 545,34 | −758 023 | 40 254 272 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −405 | 75 205 | −0,54 | 544,57 | −220 551 | 40 954 387 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −1 260 | 75 610 | −1,64 | 543,12 | −684 331 | 41 065 303 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −496 | 76 870 | −0,64 | 542,66 | −269 159 | 41 714 274 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −1 600 | 77 366 | −2,03 | 541,66 | −866 656 | 41 906 068 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −1 | 78 966 | 0,00 | 556,62 | −557 | 43 954 055 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 5 000 | 78 967 | 6,76 | 177,82 | 889 100 | 14 041 912 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 8 500 | 73 967 | 12,98 | 273,67 | 2 326 195 | 20 242 549 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 10 838 | 65 467 | 19,84 | 413,33 | 4 479 671 | 27 059 475 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 9 212 | 54 629 | 20,28 | 520,01 | 4 790 332 | 28 407 626 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 7 830 | 45 417 | 20,83 | 376,69 | 2 949 483 | 17 108 130 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 4 960 | 37 587 | 15,20 | 380,95 | 1 889 512 | 14 318 768 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 3 784 | 32 627 | 13,12 | 371,40 | 1 405 378 | 12 117 668 | |
2020-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 28 843 | 0,00 | 528,78 | −529 | 15 251 602 |
2020-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 28 844 | 0,00 | 527,44 | −527 | 15 213 479 |
2020-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 28 845 | −0,02 | 524,39 | −3 146 | 15 126 030 |
2020-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 28 851 | 0,00 | 523,36 | −523 | 15 099 459 |
2020-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 | 28 852 | −0,02 | 522,61 | −3 658 | 15 078 344 |
2020-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −17 | 28 859 | −0,06 | 521,36 | −8 863 | 15 045 928 |
2020-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −22 | 28 876 | −0,08 | 520,46 | −11 450 | 15 028 803 |
2020-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −18 | 28 898 | −0,06 | 519,54 | −9 352 | 15 013 667 |
2020-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −15 | 28 916 | −0,05 | 518,57 | −7 779 | 14 994 970 |
2020-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −12 | 28 931 | −0,04 | 517,41 | −6 209 | 14 969 189 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 28 943 | 0,00 | 495,66 | −496 | 14 345 887 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 28 944 | 0,00 | 493,35 | −493 | 14 279 522 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 28 945 | −0,01 | 492,71 | −1 478 | 14 261 491 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 28 948 | −0,01 | 491,13 | −982 | 14 217 231 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 28 950 | 0,00 | 490,35 | −490 | 14 195 632 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 | 28 951 | −0,02 | 489,56 | −2 448 | 14 173 252 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −10 | 28 956 | −0,03 | 488,62 | −4 886 | 14 148 481 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 28 966 | 0,00 | 487,54 | −488 | 14 122 084 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 28 967 | −0,01 | 486,53 | −1 946 | 14 093 315 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 28 971 | −0,01 | 485,65 | −1 457 | 14 069 766 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 | 28 974 | −0,03 | 484,54 | −3 876 | 14 039 062 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −11 | 28 982 | −0,04 | 483,49 | −5 318 | 14 012 507 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −14 | 28 993 | −0,05 | 482,43 | −6 754 | 13 987 093 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 29 007 | −0,01 | 481,34 | −1 925 | 13 962 229 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −8 | 29 011 | −0,03 | 480,55 | −3 844 | 13 941 236 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −18 | 29 019 | −0,06 | 479,60 | −8 633 | 13 917 512 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 29 037 | −0,01 | 478,45 | −1 914 | 13 892 753 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 29 041 | −0,01 | 477,58 | −955 | 13 869 401 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 | 29 043 | −0,01 | 469,49 | −1 878 | 13 635 398 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −24 | 29 047 | −0,08 | 468,14 | −11 235 | 13 598 063 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −19 | 29 071 | −0,07 | 467,51 | −8 883 | 13 590 983 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −23 | 29 090 | −0,08 | 466,60 | −10 732 | 13 573 394 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −16 | 29 113 | −0,05 | 465,35 | −7 446 | 13 547 735 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 | 29 129 | −0,03 | 464,49 | −4 180 | 13 530 129 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 | 29 138 | −0,01 | 463,16 | −1 389 | 13 495 556 |
2020-04-01 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 | 29 141 | −0,01 | 462,80 | −926 | 13 486 455 |
2020-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 4 361 | 4 361 | |||||
2020-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 320 | 29 143 | 1,11 | ||||
2019-02-15 |
|
4 | CFG |
CITIZENS FINANCIAL GROUP INC/RI
Common Stock |
A - Award | 31 | 60 994 | 0,05 | ||||
2019-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3 784 | 3 784 | |||||
2019-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
A - Award | 323 | 28 823 | 1,13 | ||||
2019-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −2 500 | 28 500 | −8,06 | ||||
2019-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −1 000 | 31 000 | −3,12 | ||||
2018-11-16 |
|
4 | CFG |
CITIZENS FINANCIAL GROUP INC/RI
Common Stock |
A - Award | 26 | 60 963 | 0,04 | ||||
2018-08-16 |
|
4 | CFG |
CITIZENS FINANCIAL GROUP INC/RI
Common Stock |
A - Award | 23 | 60 937 | 0,04 | ||||
2018-05-17 |
|
4 | CFG |
CITIZENS FINANCIAL GROUP INC/RI
Common Stock |
A - Award | 18 | 60 914 | 0,03 | ||||
2018-04-27 |
|
4 | CFG |
CITIZENS FINANCIAL GROUP INC/RI
Common Stock |
A - Award | 2 977 | 60 896 | 5,14 | ||||
2018-02-16 |
|
4 | CFG |
CITIZENS FINANCIAL GROUP INC/RI
Common Stock |
A - Award | 2 | 57 919 | 0,00 | ||||
2018-02-05 |
|
5 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −1 000 | 32 000 | −3,03 | ||||
2018-02-05 |
|
5 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −2 500 | 33 000 | −7,04 | ||||
2018-01-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 7 439 | 7 439 | |||||
2017-11-16 |
|
4 | CFG |
CITIZENS FINANCIAL GROUP INC/RI
Common Stock |
A - Award | 2 | 57 917 | 0,00 | ||||
2017-08-18 |
|
4 | CFG |
CITIZENS FINANCIAL GROUP INC/RI
Common Stock |
A - Award | 2 | 57 915 | 0,00 | ||||
2017-08-03 |
|
4 | CFG |
CITIZENS FINANCIAL GROUP INC/RI
Common Stock |
A - Award | 418 | 57 913 | 0,73 | ||||
2017-04-28 |
|
4 | CFG |
CITIZENS FINANCIAL GROUP INC/RI
Common Stock |
A - Award | 2 717 | 57 495 | 4,96 | ||||
2017-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 7 830 | 7 830 | |||||
2016-11-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −1 000 | 35 500 | −2,74 | ||||
2016-11-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 000 | 36 500 | −5,19 | 429,34 | −858 680 | 15 670 910 | |
2016-05-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −1 000 | 38 500 | −2,53 | ||||
2016-05-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 000 | 39 500 | −2,47 | 396,64 | −396 640 | 15 667 280 | |
2016-05-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −1 000 | 40 500 | −2,41 | ||||
2016-04-29 |
|
4 | CFG |
CITIZENS FINANCIAL GROUP INC/RI
Common Stock |
A - Award | 4 233 | 54 778 | 8,37 | ||||
2016-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 9 212 | 9 212 | |||||
2016-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −6 000 | 41 500 | −12,63 | ||||
2015-10-01 |
|
4 | CFG |
CITIZENS FINANCIAL GROUP INC/RI
Common Stock |
A - Award | 604 | 50 545 | 1,21 | 23,86 | 14 411 | 1 206 004 | |
2015-05-06 |
|
4 | CFG |
CITIZENS FINANCIAL GROUP INC/RI
Common Stock |
A - Award | 2 858 | 49 941 | 6,07 | ||||
2015-02-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 250 | 8 500 | −33,33 | ||||
2015-02-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 5 000 | −66,67 | ||||
2015-02-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 5 000 | −66,67 | ||||
2015-02-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2015-02-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −750 | 47 500 | −1,55 | 424,58 | −318 435 | 20 167 550 | |
2015-02-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −18 174 | 48 250 | −27,36 | 423,31 | −7 693 236 | 20 424 708 | |
2015-02-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −8 196 | 66 424 | −10,98 | 422,52 | −3 462 974 | 28 065 468 | |
2015-02-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 130 | 74 620 | −2,78 | 421,72 | −898 264 | 31 468 746 | |
2015-02-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 000 | 76 750 | 6,97 | 33,42 | 167 100 | 2 564 985 | |
2015-02-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 000 | 71 750 | 16,19 | 57,11 | 571 100 | 4 097 642 | |
2015-02-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 000 | 61 750 | 19,32 | 177,82 | 1 778 200 | 10 980 385 | |
2015-02-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 250 | 51 750 | 8,95 | 273,67 | 1 163 098 | 14 162 422 | |
2015-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 10 838 | 10 838 | |||||
2015-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −2 355 | 47 500 | −4,72 | ||||
2014-09-30 |
|
4 | CFG |
CITIZENS FINANCIAL GROUP INC/RI
Common Stock |
P - Purchase | 45 000 | 47 083 | 2 160,35 | 21,50 | 967 500 | 1 012 284 | |
2014-09-30 |
|
4 | CFG |
CITIZENS FINANCIAL GROUP INC/RI
Common Stock |
A - Award | 2 083 | 2 083 | |||||
2014-01-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12 750 | 12 750 | |||||
2013-08-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −10 958 | 49 855 | −18,02 | 238,47 | −2 613 154 | 11 888 922 | |
2013-08-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 10 000 | −33,33 | ||||
2013-08-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 10 000 | −33,33 | ||||
2013-08-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 5 000 | −66,67 | ||||
2013-08-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 5 000 | −66,67 | ||||
2013-08-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | −1 206 | 60 813 | −1,94 | 236,64 | −285 388 | 14 390 788 | |
2013-08-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 000 | 62 019 | 8,77 | 57,11 | 285 550 | 3 541 905 | |
2013-08-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | −1 412 | 57 019 | −2,42 | 236,64 | −334 136 | 13 492 976 | |
2013-08-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 000 | 58 431 | 20,65 | 33,42 | 334 200 | 1 952 764 | |
2013-08-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | −1 031 | 48 431 | −2,08 | 236,64 | −243 976 | 11 460 712 | |
2013-08-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 000 | 49 462 | 25,34 | 24,41 | 244 100 | 1 207 367 | |
2013-08-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | −393 | 39 462 | −0,99 | 236,64 | −93 000 | 9 338 288 | |
2013-08-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 000 | 39 855 | 14,35 | 18,61 | 93 050 | 741 702 | |
2013-05-31 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −500 | 34 855 | −1,41 | 249,45 | −124 725 | 8 694 580 | |
2013-05-31 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 000 | 35 355 | −5,35 | 249,58 | −499 160 | 8 823 901 | |
2013-05-31 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −3 000 | 37 355 | −7,43 | ||||
2013-01-14 |
|
4 | UBPS |
Universal Business Payment Solutions Acquisition Corp
Call Options (obligation to sell) |
S - Sale | −2 | 2 | −50,00 | ||||
2013-01-14 |
|
4 | UBPS |
Universal Business Payment Solutions Acquisition Corp
Common Stock, par value $0.001 |
D - Sale to Issuer | 16 266 | 40 213 | 67,93 | ||||
2013-01-14 |
|
4 | UBPS |
Universal Business Payment Solutions Acquisition Corp
Common Stock, par value $0.001 |
S - Sale | −20 953 | 13 547 | −60,73 | 0,01 | −174 | 112 | |
2013-01-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2012-11-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −10 000 | 40 355 | −19,86 | 145,57 | −1 455 700 | 5 874 477 | |
2012-11-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −7 000 | 60 355 | −10,39 | ||||
2012-10-03 |
|
4 | UBPS |
Universal Business Payment Solutions Acquisition Corp
Common Stock, par value $0.001 per share |
P - Purchase | 1 000 | 35 500 | 2,90 | 6,05 | 6 050 | 214 775 | |
2012-08-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −10 000 | 57 355 | −14,85 | 136,15 | −1 361 500 | 7 808 883 | |
2012-01-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −17 100 | 67 355 | −20,25 | 79,09 | −1 352 439 | 5 327 107 | |
2012-01-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −8 400 | 84 455 | −9,05 | 78,86 | −662 424 | 6 660 121 | |
2012-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2011-05-25 | 3 | UBPS |
Universal Business Payment Solutions Acquisition Corp
Common Stock, par value $0.001 per share |
34 500 |